Company Filing History:
2 out of 191 
1 out of 3 Years Active: 2008-2012
Title: Daiju Okuda: Innovator in Antibacterial Peptides
Introduction
Daiju Okuda is a prominent inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibacterial agents. With a total of two patents to his name, Okuda's work focuses on innovative solutions to combat bacterial infections.
Latest Patents
Okuda's latest patents revolve around a novel peptide based on CAP11. This invention provides an antibacterial agent, an LPS-cell-binding inhibitor, and a drug for treating bacterial infections or endotoxin shock. The peptide features a specific amino acid sequence (SEQ ID NO: 1) that includes cationic and non-polar amino acid residues. Each of these components contains the peptide as an active ingredient, showcasing Okuda's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Daiju Okuda has worked with notable organizations such as Seikagaku Corporation and Juntendo University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Okuda's coworkers include Isao Nagaoka and Shin Yomogida. Their collaborative efforts have further enhanced the impact of Okuda's inventions in the scientific community.
Conclusion
Daiju Okuda's innovative work in the development of antibacterial peptides highlights his significant role in advancing medical science. His contributions continue to pave the way for new treatments in the fight against bacterial infections.